Ellison Medical Institute · 2 hours ago
Director, Business Development & Transactions
Ellison Medical Institute is a medical research and development center focused on enhancing health and redefining cancer care. They are seeking an experienced Director of Business Development & Transactions to lead strategic partnerships and licensing efforts that will expand their pipeline and accelerate clinical development.
Biotechnology
Responsibilities
Lead structuring, negotiation, and execution of term sheets and definitive agreements for in-licensing, out-licensing, co-development, and strategic collaborations
Develop creative deal architectures, including options-to-license, regional rights, risk-sharing structures, and co-development models
Negotiate and finalize collaboration agreements with academic institutions, research hospitals, technology developers, and data platform partners
Drive internal alignment across scientific, clinical, finance, and legal functions
Present opportunities and recommendations to senior leadership and ensure seamless transition to alliance management post-deal
Identify and evaluate external technologies, discovery platforms, and therapeutic assets aligned with Institute priorities
Assess internal programs for partnering or out-licensing opportunities as they progress toward clinical development
Lead and coordinate cross-functional due diligence, including scientific, clinical, regulatory, IP, and financial assessments
Analyze market opportunities, scenarios, risks, and projected value creation
Integrate market intelligence, competitive landscape insights, and deal trend analyses to guide strategic decision-making
Develop valuation models and financial forecasts to support business cases
Contribute to long-range portfolio and partnership strategy with executive leadership
Represent the Institute at partnering conferences, investor events, and scientific meetings
Build and maintain productive relationships with biotech, pharma, venture, and academic partners
Cultivate a broad network enabling early access to emerging technologies and scientific innovation
Qualification
Required
Master's or Ph.D. in a relevant scientific discipline (e.g., biology, chemistry, pharmacology, or related field)
MBA strongly preferred; must demonstrate strong grounding in strategy, finance, and valuation
10+ years of biotech/pharma experience in business development, licensing, or corporate development
Proven track record leading and closing in-licensing, out-licensing, and co-development transactions spanning preclinical through Phase 1-2 development
Experience in both large/mid-cap pharma or biotech and fast-paced start-up environments strongly preferred
Comprehensive understanding of drug discovery, translational research, clinical development, and regulatory pathways
High scientific fluency with the ability to partner effectively with discovery, translational, and clinical leaders
Advanced proficiency in financial modeling, valuation, deal structuring, and strategic analysis
Strategic, entrepreneurial mindset with disciplined execution
Ability to integrate scientific, clinical, commercial, and financial perspectives into sound business decision-making
Strong deal leadership—able to independently drive transactions from sourcing through signed agreement
Exceptional communication skills with executive presence and the ability to influence across functions and levels
Motivated by building partnerships that advance science and deliver meaningful patient impact
Preferred
Experience in both large/mid-cap pharma or biotech and fast-paced start-up environments strongly preferred
Benefits
Bonus eligibility
Comprehensive benefits package
Company
Ellison Medical Institute
Formerly known as the Ellison Institute of Technology Los Angeles, the Ellison Medical Institute strives to spark innovation, leverage technology, and drive interdisciplinary, patient-centered research to continually enhance health, reimagine and redefine cancer care, and transform lives.
Funding
Current Stage
Growth StageRecent News
businessweekly.co.uk
2025-04-11
Company data provided by crunchbase